A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis and fractures, according to new research by Weill Cornell Medicine scientists.
The findings, published May 21 in Nature Medicine, show that a substance, which is best known for spurring nerve growth, called SLIT3, both reversed the bone-weakening effects of osteoporosis and helped fractures heal when administered in mice. The multi-center research effort could fuel drug development efforts targeting the SLIT3 pathway in humans, enabling a new approach for blood vessel-directed therapy to treat bone loss, persistent fractures and fragile bones.
Existing drugs for osteoporosis work in one of two ways: Either they block the cells that destroy bone or they promote bone formation by cells called osteoblasts. “But only those promoting new bone formation will help you actually heal a bone fracture,” said co-senior study author Dr. Matthew Greenblatt, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine. “Our findings have potentially demonstrated a third category: drugs that target blood vessel formation within bone, prompting new bone to form.”
Osteoporosis, which causes bones to thin and become brittle, leads to nearly 9 million fractures worldwide each year, or one every three seconds, according to the International Osteoporosis Foundation. Women are disproportionately affected, and the risk increases with age. One in two women and one in five men will have an osteoporotic fracture during their lifetimes, and these fractures kill as many women each year as breast cancer.
“Osteoporosis and skeletal fractures due to osteoporosis are both common and deadly,” Dr. Greenblatt said.
To counteract that trend, Dr. Greenblatt has been investigating the cellular causes of osteoporosis in an effort to promote bone growth. Prior research using mice genetically engineered to lack an adaptor protein known as SHN3 showed that its absence conferred high bone mass. Building on that discovery, Dr. Greenblatt and his team decided to examine the resulting changes in bone blood vessels. “We used those mice as a means to find the signals coming from osteoblasts to control the specific type of blood vessels present in bone,” he said.
The researchers were surprised to find that osteoblasts secreted unchanged amounts of almost all known factors promoting blood vessel growth, but SLIT3 levels rose significantly. And when the mice were genetically altered to delete SLIT3, they exhibited low bone mass. “We next asked if we could use SLIT3 to treat mice with skeletal disease, especially osteoporosis and fracture healing,” Dr. Greenblatt said. “When we gave the rodents SLIT3, it reversed their osteoporosis and made their fractures heal faster and stronger.”
“To my knowledge, this is the first example that we can develop a drug to treat bone disease in mice not by targeting the bone-forming cells,” he said, “but instead by targeting special types of blood vessels that exist in bone.”
Further research is needed to determine the best way to deliver SLIT3 to the bone in humans. SLIT3-pathway drugs could also be used in combination with existing drugs to improve patient outcomes.
“Only a small fraction of patients who’ve had a hip fracture and really require medication to prevent additional fractures get the drugs they need. Many people aren’t aware of how debilitating and deadly these kinds of fractures are,” Dr. Greenblatt said. “Having a totally new category of bone drugs that work on different sets of cells could open up new opportunities for treatment.”
In addition to benefiting seniors with osteoporosis, Dr. Greenblatt hopes his research will also help patients with bone injuries that aren’t healing properly, such as those who’ve undergone orthopedic surgery or have fragile bones due to genetic diseases. “Some of those people’s fractures don’t heal because they can’t grow the right type of blood vessels at the site of the fracture,” he said. “That’s what we think SLIT3 will do: help with that growth and promote healing.”
Learn more: Molecule Promoting Blood Vessel Growth in Bone Represents New Target for Osteoporosis Drugs
The Latest on: Osteoporosis
[google_news title=”” keyword=”osteoporosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Osteoporosis
- What Harvard Health Publishing And 3 Other Doctors Think: What Is The Best Diet Or Foods To Help With Osteoporosis?on May 9, 2024 at 2:45 am
Answered by Dr. Robert H. Shmerling M.D. Senior Faculty Editor, Harvard Health Publishing · 30 years of experience · USA There is no single best diet for people with osteoporosis. However, it is ...
- Can adequate sleep prevent osteoporosis? Study sheds lighton May 8, 2024 at 7:45 pm
In a study from the University of Colorado Department of Medicine, researchers investigated whether adequate sleep can help prevent osteoporosis.Osteoporosis is a condition characterized ...
- Women’s Health Wednesday: Osteoporosis Awarenesson May 8, 2024 at 12:23 pm
Women are four times more likely than men, to develop Osteoporosis. This is a weakening of the bone, specifically the structure of the bone itself.
- New research investigates whether adequate sleep can help prevent osteoporosison May 7, 2024 at 10:40 pm
"Osteoporosis can occur for many reasons such as hormonal changes, aging, and lifestyle factors," said Swanson, an associate professor in the Division of Endocrinology, Metabolism, and Diabetes. "But ...
- Preventing Osteoporosis: Free education series for the community May 23on May 7, 2024 at 12:11 pm
CHI Health St. Francis, in collaboration with Nebraska Heart Institute, is hosting a heart-education session at 6:30 p.m. on Thursday, May 23.
- How Long to Take Alendronate for Osteoporosis?on May 6, 2024 at 4:59 pm
Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...
- Osteoporosis and resistance trainingon May 5, 2024 at 5:06 pm
THE phrase “out of sight and out of mind” applies perfectly to our bones.“We rarely pay attention to our bones,”says family physician Dr Sasha Farrier who sees patients at the ...
- Osteoporosis Newson May 4, 2024 at 5:00 pm
Feb. 21, 2024 — With ever-increasing life expectancy comes the challenge of treating age-related disorders such as osteoporosis. Although there are effective drugs for treating this metabolic ...
- Enhance Bone Strength and Balance With These Two Exercise Classes That Can Help Prevent Osteoporosison April 30, 2024 at 10:47 am
Osteoporosis is a health risk that unfortunately increases as we age since our bone density changes. The condition weakens your bones and makes them more susceptible to breaks and fractures, and the ...
- Osteoporosis: What leads to bone fractures and can it be reversed?on April 30, 2024 at 6:17 am
Osteoporosis is a "deceptive condition" that continues to be a global health concern. In India, women are more susceptible to this bone disease.
via Bing News